Literature DB >> 1379809

Identification of osteopontin in isolated rabbit osteoclasts.

K Tezuka1, T Sato, H Kamioka, P J Nijweide, K Tanaka, T Matsuo, M Ohta, N Kurihara, Y Hakeda, M Kumegawa.   

Abstract

Bone remodeling is a complex process coupling bone formation and resorption. Osteoblasts, the bone-forming cells, are known to produce various bone matrix proteins and cytokines; however, little is known about protein factors produced by osteoclasts or bone-resorbing cells. A method utilizing the high affinity of osteoclasts for tissue culture dishes was developed to isolate a large number of pure osteoclasts from rabbit long bones. A cDNA library was then constructed from these isolated osteoclasts, and differential cDNA screening was performed between osteoclasts and spleen cells. Two clones representing osteoclast-specific clones, named OC-1 and OC-2, were isolated. By Northern blot analysis, OC-1 was expressed in osteoclasts and in kidneys, whereas OC-2 was specific for osteoclasts. OC-1 was found to encode osteopontin from its nucleotide sequence, and therefore, osteopontin may have other functions for osteoclastic bone resorption besides osteoclast attachment to bone.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1379809     DOI: 10.1016/0006-291x(92)90832-6

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  24 in total

1.  Osteoclast responses to lipopolysaccharide, parathyroid hormone and bisphosphonates in neonatal murine calvaria analyzed by laser scanning confocal microscopy.

Authors:  Keiko Suzuki; Sadaaki Takeyama; Takashi Kikuchi; Shoji Yamada; Jaro Sodek; Hisashi Shinoda
Journal:  J Histochem Cytochem       Date:  2005-08-08       Impact factor: 2.479

2.  Localization of osteopontin in resorption lacunae formed by osteoclast-like cells: a study by a novel monoclonal antibody which recognizes rat osteopontin.

Authors:  H Maeda; T Kukita; A Akamine; A Kukita; T Iijima
Journal:  Histochemistry       Date:  1994-10

3.  Expression of the gene encoding the matrix gla protein by mature osteoblasts in human fracture non-unions.

Authors:  D M Lawton; J G Andrew; D R Marsh; J A Hoyland; A J Freemont
Journal:  Mol Pathol       Date:  1999-04

4.  Zinc compounds inhibit osteoclast-like cell formation at the earlier stage of rat marrow culture but not osteoclast function.

Authors:  M Yamaguchi; S Kishi
Journal:  Mol Cell Biochem       Date:  1996-05-24       Impact factor: 3.396

5.  Localization of transglutaminase-reactive glutamine residues in bovine osteopontin.

Authors:  E S Sørensen; L K Rasmussen; L Møller; P H Jensen; P Højrup; T E Petersen
Journal:  Biochem J       Date:  1994-11-15       Impact factor: 3.857

6.  Expression of wild-type and mutated rabbit osteopontin in Escherichia coli, and their effects on adhesion and migration of P388D1 cells.

Authors:  K Nasu; T Ishida; M Setoguchi; Y Higuchi; S Akizuki; S Yamamoto
Journal:  Biochem J       Date:  1995-04-01       Impact factor: 3.857

7.  Valproic acid exerts anti-tumor as well as anti-angiogenic effects on myeloma.

Authors:  Ken-Ichi Kitazoe; Masahiro Abe; Masahiro Hiasa; Asuka Oda; Hiroe Amou; Takeshi Harada; Ayako Nakano; Kyoko Takeuchi; Toshihiro Hashimoto; Shuji Ozaki; Toshio Matsumoto
Journal:  Int J Hematol       Date:  2008-12-18       Impact factor: 2.490

8.  Molecular cloning and expression of a unique rabbit osteoclastic phosphotyrosyl phosphatase.

Authors:  L W Wu; D J Baylink; K H Lau
Journal:  Biochem J       Date:  1996-06-01       Impact factor: 3.857

9.  Posttranslational modifications of bovine osteopontin: identification of twenty-eight phosphorylation and three O-glycosylation sites.

Authors:  E S Sørensen; P Højrup; T E Petersen
Journal:  Protein Sci       Date:  1995-10       Impact factor: 6.725

10.  Human breast adenocarcinoma (MDA-231) and human lung squamous cell carcinoma (Hara) do not have the ability to cause bone resorption by themselves during the establishment of bone metastasis.

Authors:  Amy Tomita; Tatsuhiko Kasaoka; Takashi Inui; Minako Toyoshima; Hiroko Nishiyama; Hiromasa Saiki; Haruo Iguchi; Motowo Nakajima
Journal:  Clin Exp Metastasis       Date:  2008-02-27       Impact factor: 5.150

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.